Background:Spinal muscular atrophy (SMA) is a rare autosomal recessive inherited neuromuscular disease with about 1:6000 to 1:10,000 in newborns.
Objectives:To evaluate the copy number variation of SMN1 and SMN2 genes between two generations, we experimented on 221 core families, including 221 patients and their parents (n=442).
Materials & methods: Before sample collection, all cases were subjected to clinical diagnosis, electromyography, and nerve conduction velocity test. Moreover, DNA samples were analyzed by multiplex ligation-dependent probe amplification.
Results: In this study, 92.7% of patients' SMN1 deletions were homozygous, whereas 7.3% of the SMN1 deletions were heterozygous. On the other hand, 92.9% of the parents had one copy of SMN1, and the remaining had two copies of SMN1. Since SMN2 has a disease-modifying role, accurate determination of SMN2 copy number can be helpful in the case of prognosis and genotype-phenotype correlation. The average SMN copies from parents represent the copy number in the parent's generation. Evaluations showed a negative correlation between the copy number of SMN1 and SMN2in children and their parents. Besides, when the average of SMN2 copy numbers was two in the parent's generation, 81% of the children were type I, and the rest were Type II/III. Also, in cases with three or more SMN2copy numbers in parents, approximately 90% of children were either type II or III.
Conclusion: Accordingly, there is a possibility that the SMN2 copy numbers in parents could predict the disease severity in the next generation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.